Limited-stage Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Limited-stage Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC) [Phase 3]
A Phase 3 clinical trial evaluating tarlatamab after chemoradiotherapy in limited-stage small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: A Prospective, Multicenter Exploratory Clinical Study on Consolidation Therapy With Tislelizumab Combined With Nintedanib for Limited-stage Small Cell Lung Cancer [Phase 4]
This release describes a Phase 4, multicenter exploratory trial evaluating consolidation therapy with tislelizumab in combination with ninte…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer [Phase 3]
Phase 3 trial evaluating trilaciclib to prevent myelosuppression in limited-stage small cell lung cancer; status shows not yet recruiting.
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial is evaluating the combination of toripalimab and surufatinib with concurrent chemoradiotherapy for limited-stage sm…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in the Treatment of Limited-stage Small Cell Lung Cancer (LS-SCLC) [Phase 2]
A Phase 2 clinical trial update from Fudan University evaluating probiotics with concurrent hyperfractionated chemoradiotherapy and maintena…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC Patients [Phase 2]
A Phase 2 clinical trial is evaluating tarlatamab as maintenance therapy after chemo-radiotherapy in patients with limited-stage small cell …
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Serplulimab in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung Cancer [Phase 3]
This clinical trial update describes a Phase 3 study evaluating serplulimab in combination with chemotherapy and concurrent radiotherapy for…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Durvalumab as Consolidation Therapy in Patients With LS-SCLC Following sCRT
This clinical trial update notes recruitment for a study evaluating durvalumab as consolidation therapy after definitive chemoradiation in p…
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: A Study of QL1706 Combined With Chemotherapy Induction on Sequential Immunotherapy Consolidation in Patients With Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy [Phase 2]
A Phase 2 clinical trial evaluating QL1706 with chemotherapy induction for sequential immunotherapy consolidation in patients with limited-s…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC) [Phase 3]
A Phase 3 clinical trial is evaluating adding atezolizumab to standard chemoradiation for limited-stage small cell lung cancer; the study is…
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: Omitting CTV for Primary Tumor in LS-SCLC [Phase 3]
Phase 3 clinical trial update evaluating omitting the clinical target volume (CTV) for the primary tumor in limited-stage small cell lung ca…
-
CLINICAL_TRIALS research · 2025-04-25Clinical Trial Update: Hypofractionated Radiotherapy Followed by Chemo-immunotherapy Induction Therapy [Phase 2]
A Phase 2 trial is investigating hypofractionated radiotherapy followed by chemo-immunotherapy induction in limited-stage small cell lung ca…
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: Prediction of Response to PD-L1 Inhibitor After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer Using Multi-omics-based Liquid Biopsy
A recruiting study evaluating whether multi-omics-based liquid biopsy can predict response to PD-L1 inhibitors after chemoradiotherapy in li…
-
CLINICAL_TRIALS research · 2025-01-14Clinical Trial Update: Adjuvant Adebrelimab Plus Apatinib After Chemoradiation in Limited-Stage Small Cell Lung Cancer [Phase 2]
Phase 2 trial update evaluating adjuvant adebrelimab plus apatinib after chemoradiation in limited-stage small cell lung cancer; currently e…
-
CLINICAL_TRIALS research · 2024-07-30Clinical Trial Update: A Study of HS-20093 vs Active Surveillance in Limited-Stage Small Cell Lung Cancer [Phase 3]
This document describes a Phase 3 clinical trial comparing HS-20093 to active surveillance in patients with limited-stage small cell lung ca…
-
CLINICAL_TRIALS research · 2024-05-29Clinical Trial Update: Neoadjuvant Therapy With Toripalimab and JS004 Combined With Etoposide and Platinum Chemotherapy for Limited-stage Small Cell Lung Cancer : A Phase 2 Trial [Phase 2]
A Phase 2 neoadjuvant trial in limited-stage small cell lung cancer combines toripalimab and JS004 with etoposide and platinum chemotherapy,…
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: Consolidation Serplulimab Following Concurrent Chemoradiotherapy for LS-SCLC Patients [Phase 2]
Phase 2 clinical trial update evaluating consolidation serplulimab after concurrent chemoradiotherapy in patients with Limited Stage Small C…
-
CLINICAL_TRIALS research · 2012-10-19Clinical Trial Update: Once Daily Accelerated Fractionation With Concomitant Boost to the Gross Tumor Volume Compared With Twice Daily Hyperfractionation in Concurrent Chemoradiation in Patients With Limited Disease Small Cell Lung Cancer [Phase 2]
Phase 2 trial comparing once-daily accelerated fractionation with a concomitant GTV boost to twice-daily hyperfractionation in concurrent ch…